Tomás Sobrino Selected Research

Tomás Sobrino Research Topics

Disease

58	Stroke (Strokes) 02/2024 - 01/2006
53	Ischemic Stroke 12/2023 - 01/2007
25	Inflammation (Inflammations) 01/2023 - 01/2006
18	Brain Ischemia (Cerebral Ischemia) 01/2022 - 06/2007
13	Infarction (Infarctions) 01/2024 - 01/2006
11	Periodontitis 11/2023 - 01/2019
9	Migraine Disorders (Migraine) 03/2020 - 05/2007
9	Ischemia 10/2018 - 01/2006
8	Hematoma 07/2021 - 01/2007
8	Cerebral Hemorrhage 12/2020 - 12/2009
6	Keratoconus 10/2022 - 10/2010
6	Brain Injuries (Brain Injury) 01/2018 - 01/2008
5	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 01/2020
5	Necrosis 02/2024 - 01/2016
5	Leukoaraiosis 02/2024 - 10/2009
4	Edema (Dropsy) 01/2024 - 01/2007
4	Obesity 02/2022 - 01/2019
4	Embolic Stroke 01/2022 - 07/2013
3	Cognitive Dysfunction 02/2024 - 03/2021
3	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022 - 01/2020
3	Body Weight (Weight, Body) 02/2022 - 01/2019
3	Lacunar Stroke 01/2019 - 01/2006
3	Brain Edema (Cerebral Edema) 12/2012 - 01/2007
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2024 - 10/2018
2	Cerebral Infarction 01/2021 - 01/2007
2	Hypothermia 01/2020 - 01/2016
2	Atrial Fibrillation 01/2019 - 07/2013
2	Hemorrhage 01/2018 - 06/2017
2	Asphyxia (Suffocation) 01/2017 - 01/2016
2	Transient Ischemic Attack 01/2017 - 08/2013
2	Hemorrhagic Stroke 04/2010 - 01/2009
1	Atrophy 02/2024
1	Nervous System Diseases (Neurological Disorders) 01/2023

Drug/Important Bio-Agent (IBA)

29	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2006
19	Glutamic Acid (Glutamate)FDA Link 06/2022 - 03/2006
17	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2006
12	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2023 - 01/2007
10	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 01/2009
9	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2006
9	EnzymesIBA 07/2022 - 06/2011
8	Oxaloacetic Acid (Oxalacetic Acid)IBA 01/2017 - 06/2011
7	Neuroprotective AgentsIBA 01/2022 - 06/2008
7	Transaminases (Aminotransferases)IBA 01/2017 - 06/2011
6	Fibronectins (Fibronectin)IBA 01/2023 - 06/2007
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2011
6	IronIBA 08/2021 - 01/2007
6	erucylphosphocholineIBA 04/2017 - 10/2007
5	C-Reactive ProteinIBA 06/2022 - 01/2018
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 12/2009
4	Amyloid beta-PeptidesIBA 02/2024 - 10/2009
4	Endothelin-1 (Endothelin 1)IBA 01/2023 - 07/2008
4	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 01/2009
4	Interleukin-10 (Interleukin 10)IBA 10/2021 - 06/2013
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2020 - 05/2007
4	Peptides (Polypeptides)IBA 01/2020 - 10/2009
3	CeramidesIBA 07/2022 - 01/2021
3	SphingolipidsIBA 07/2022 - 01/2021
3	Therapeutic UsesIBA 01/2022 - 01/2017
3	PTX3 proteinIBA 03/2020 - 01/2018
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 06/2007
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 12/2009
3	NeuroserpinIBA 05/2011 - 02/2011
3	Ferritins (Ferritin)IBA 04/2010 - 01/2007
2	LigandsIBA 01/2023 - 06/2011
2	Vitamin D FDA LinkGeneric 06/2022 - 03/2021
2	InterleukinsIBA 02/2022 - 06/2011
2	LeptinIBA 02/2022 - 01/2018
2	AdiponectinIBA 02/2022 - 01/2018
2	AnticoagulantsIBA 01/2022 - 01/2019
2	LipidsIBA 10/2021 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2021 - 10/2020
2	Matrix Metalloproteinases (MMPs)IBA 07/2021 - 07/2020
2	Amyloid (Amyloid Fibrils)IBA 07/2021 - 01/2013
2	tau Proteins (tau Protein)IBA 07/2021 - 01/2020
2	Type A Botulinum Toxins (Botox)FDA Link 01/2021 - 01/2020
2	Calcitonin Gene-Related PeptideIBA 10/2019 - 07/2012
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2019 - 02/2011
2	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 01/2006
2	Collagenases (Collagenase)FDA Link 10/2018 - 07/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2017 - 01/2016
2	Cytidine Diphosphate Choline (Citicoline)IBA 01/2013 - 07/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2012 - 06/2008
2	Excitatory Amino Acid AntagonistsIBA 02/2012 - 03/2006
2	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 07/2008 - 06/2007
1	Polyvinyl Chloride (PVC)IBA 02/2024
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 01/2024
1	ChemokinesIBA 01/2024
1	CytokinesIBA 01/2024
1	Hemostatics (Antihemorrhagics)IBA 12/2023
1	GraphiteIBA 01/2023
1	Chaperonin 60IBA 01/2023
1	LactoferrinIBA 10/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2022
1	FibrinIBA 10/2022
1	Contrast MediaIBA 10/2022

Therapy/Procedure

25	Therapeutics 06/2022 - 01/2006
4	Thrombolytic Therapy 01/2021 - 01/2007
2	Aftercare (After-Treatment) 06/2007 - 01/2007
1	Mediterranean Diet 01/2024
1	Thrombectomy 10/2022